🇨🇦 Nimotuzumab plus S1 in Canada

Nimotuzumab plus S1 (Nimotuzumab plus S1) regulatory status in Canada.

Marketing authorisation

Nimotuzumab plus S1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Nimotuzumab plus S1 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Nimotuzumab plus S1 in Canada?

Chinese PLA General Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.